MetaMedical™ Solutions Inc announces appointment of Geoff Martin as CEO

Health technology company has announced Geoff Martin as its new chief executive officer (CEO).

Martin will assume the responsibilities of Yonatan Adiri, who has been the company’s founder and CEO since its inception and will now transition to the role of president.

In his new role, Adiri will focus on long-term strategy and public health policy. He will also spearhead the company’s financial market activities in the US.

Martin previously served as president of AI healthcare company Olive and global CEO of GE Healthcare’s Partners group.

In the new role, Martin will advance the commercialisation process and expedite the company’s sales and integration into robust pharma and health insurance markets.

Martin said: “ has made a considerable impact on patients facing chronic illness throughout the US and UK.

Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free

Your download email will arrive shortly

We are confident about the
quality of our Company Profiles. However, we want you to make the most
decision for your business, so we offer a free sample that you can download by
submitting the below form

By GlobalData

“Through its accessible services transforming smartphones into medical devices, has impacted lives in incredible ways, including preventing dialysis treatments and limb amputations among patients who typically did not receive adequate preventive care.”

Martin’s appointment comes as the company surpasses the one million patient milestone and expands its services, with individuals across the US and UK testing for chronic illness using their smartphones.

Furthermore, co-founder and product leader Ron Zohar will join the company’s board and lead the development of advanced AI technologies within the company.

Zohar’s focus will also be on developing partnerships across the globe to support the company’s growth strategy.

Adiri said: “12 years ago, in the days of the iPhone 4, we set out on a journey with the ambitious idea that combining artificial intelligence with a phone camera would allow a smartphone to become a lab-grade scanner.

“Today, after more than a million patients have used our FDA-cleared solutions, we can confidently say that we have irreversibly changed the world of digital medicine. We are excited to have Geoff joining our team as CEO to help expedite our long-term plans.” has developed the smartphone-powered at-home kidney test, which has been cleared by the US Food and Drug Administration.

Source link